© 2022 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2022 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
December 29, 2021
Study findings suggest that assessment with the simpler and more commonly available non-contrast computed tomography (CT) may widen the indication for treating patients in the extended window.
December 09, 2021
New research emphasizes roles of anterior collaterals and ischemic core growth rate in assessing patients with large vessel occlusion.
December 03, 2021
Study findings further highlight the central role of PET/CT in disease response after CAR-T cell therapy.
December 02, 2021
Early study results suggest that low-field MRI may offer a cost-effective, radiation-free alternative to monitor ventricular volume changes in patients with hydrocephalus.
Cost, lower literacy levels and fear of lung cancer diagnosis were highlighted as concerns with lung cancer screening.
Diffusion-weighted imaging may be useful as a safe and effective screening tool to supplement mammography in women with dense breast tissues.
December 01, 2021
This study discloses the characteristics of patients using self-scheduled online patient portal screening mammography.
PSMA PET is highly robust in identifying prostate cancer lesions which are otherwise deemed unremarkable.
An artificial intelligence for digital breast tomosynthesis enhances radiologists’ performance and efficiency.
November 30, 2021
Following breast cancer treatment, women who have access to breast MRI may safely forgo additional mammographic or digital breast tomosynthesis follow-up.